We currently do not have sufficient information about the CEO.
Key information
Itamar Shimrat
Chief executive officer
US$211.3k
Total compensation
CEO salary percentage
100.00%
CEO tenure
14yrs
CEO ownership
n/a
Management average tenure
no data
Board average tenure
8.2yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Itamar Shimrat's remuneration changed compared to Cell Source's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2025
n/a
n/a
-US$6m
Dec 31 2024
US$211k
US$211k
-US$6m
Sep 30 2024
n/a
n/a
-US$7m
Jun 30 2024
n/a
n/a
-US$6m
Mar 31 2024
n/a
n/a
-US$6m
Dec 31 2023
US$204k
US$204k
-US$7m
Sep 30 2023
n/a
n/a
-US$7m
Jun 30 2023
n/a
n/a
-US$7m
Mar 31 2023
n/a
n/a
-US$7m
Dec 31 2022
US$208k
US$208k
-US$6m
Sep 30 2022
n/a
n/a
-US$6m
Jun 30 2022
n/a
n/a
-US$6m
Mar 31 2022
n/a
n/a
-US$6m
Dec 31 2021
US$423k
US$204k
-US$6m
Sep 30 2021
n/a
n/a
-US$7m
Jun 30 2021
n/a
n/a
-US$6m
Mar 31 2021
n/a
n/a
-US$6m
Dec 31 2020
US$182k
US$182k
-US$5m
Sep 30 2020
n/a
n/a
-US$5m
Jun 30 2020
n/a
n/a
-US$5m
Mar 31 2020
n/a
n/a
-US$5m
Dec 31 2019
US$172k
US$172k
-US$5m
Compensation vs Market: Itamar's total compensation ($USD211.27K) is below average for companies of similar size in the US market ($USD641.77K).
Compensation vs Earnings: Itamar's compensation has increased whilst the company is unprofitable.
CEO
Itamar Shimrat (67 yo)
14yrs
Tenure
US$211,271
Compensation
Mr. Itamar Shimrat has been the Chief Executive Officer of Cell Source, Inc. since October 2013 and serves as its President. Mr. Shimrat has been its Chief Financial Officer since June 6, 2012 and served a...
Board Members
Name
Position
Tenure
Compensation
Ownership
Dennis Brown
Executive Chairman
12yrs
no data
no data
Herman Waldmann
Member of Scientific Advisory Board
no data
no data
no data
Yair Reisner
Chairman of Scientific Advisory Board
no data
no data
no data
Steven Burakoff
Member of Scientific Advisory Board
11yrs
no data
no data
Joseph Rosenthal
Member of Scientific Advisory Board
5.3yrs
no data
no data
Robert Negrin
Member of Scientific Advisory Board
11yrs
no data
no data
Hermann Einsele
Member of Scientific Advisory Board
no data
no data
no data
Darlene Soave
Director
5.3yrs
no data
no data
George Verstraete
Director
4.3yrs
no data
no data
8.2yrs
Average Tenure
81yo
Average Age
Experienced Board: CLCS's board of directors are considered experienced (8.2 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/08 03:40
End of Day Share Price
2026/06/08 00:00
Earnings
2025/03/31
Annual Earnings
2024/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cell Source, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.